Live Breaking News & Updates on Scott morrison astrazeneca

Stay informed with the latest breaking news from Scott morrison astrazeneca on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Scott morrison astrazeneca and stay connected to the pulse of your community

Australia's largest aged care provider left in limbo about staff Covid vaccines six weeks into rollout | Aged care (Australia)

Bupa runs roughly 60 aged care facilities across the country, housing more than 6,000 residents, meaning it is critically reliant on the aged care staff vaccination program.
The company told the Guardian on Thursday â more than six weeks into the rollout â it was yet to receive any plan from government for vaccinating its staff.
âAlthough an official program for our team members is yet to begin, we look forward to the governmentâs plans and acting on those to provide our staff and residents this additional protection,â a spokeswoman said late Thursday afternoon, just hours before prime minister Scott Morrisonâs AstraZeneca announcement.

Australia , Australian , Scott-morrison-astrazeneca , Ian-yates , Greg-hunt , Pfizer , Astrazeneca , Scott-morrison , ஆஸ்திரேலியா , ஆஸ்திரேலிய , ஈயந்-யேட்ஸ் , கிரெக்-வேட்டை

More shots in the dark

More shots in the dark
LIKE FINDING A NEEDLE IN A HAYSTACK
Following several missed vaccine rollout targets, weird attempts to shift blame to the states, and concerns of vaccine hesitancy due to rare blood clots linked to the AstraZeneca vaccine,
The news comes after
Greg Hunt announced the government will not purchase the Johnson & Johnson’s vaccine out of concern it carries similarly rare but severe blood clotting risks, with
Guardian Australia noting that US health agencies have officially recommended states pause administration of the drug.
Unfortunately the global production target for Australia’s third option, Novavax, has been pushed back until the third quarter of 2021 due to supply shortages. Although clinical trials for the drug are still underway, the ABC explains that Australia has an agreement for 51 million doses originally slated for “mid-2021, at which point executives had said full-scale vaccine production could be achieved”.

Sydney , New-south-wales , Australia , Afghanistan , Upper-hunter , Australians , Matt-kean , Chris-bowen , John-nichols , Robert-reich , Jodi-mckay , Ben-roberts-smith